Senior Manager, Health Research Institute, PwC US
Erin McCallister is a senior manager with PwC’s Health Research Institute and leads HRI’s analysis of regulatory and legislative affairs impacting the pharma life sciences industry.
Previously, Erin spent 12 years covering the biopharma industry at BioCentury where she focused on topics related to clinical development and market access. She analyzed FDA policies to streamline drug development via novel trial designs, patient input and real-world evidence. Erin also reported on CMS policies surrounding 340B and Medicare, and wrote about various treatment landscapes, analyzing how they were changing as new drugs were being developed and launched.
Erin served as a co-host of BioCentury's weekly DC-based healthcare policy show BioCentury This Week and has been a moderator and speaker on panels related to personalized medicine, biopharma business strategies and global drug development.
Erin has her BS degree from Purdue University and her masters in science and policy from the University of Chicago.